https://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.png00adminhttps://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.pngadmin2020-10-26 11:07:222020-10-26 12:51:27The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
https://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.png00adminhttps://sapienbio.co.in/wp-content/uploads/2015/04/Sapien-Logo_with-tagline.pngadmin2020-10-20 14:59:592022-01-18 11:24:49Breast Cancer Protection,
Recent Comments